CSIMarket
 


Adma Biologics Inc   (ADMA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ADMA's Income from Cont. Operations Growth by Quarter and Year

Adma Biologics Inc 's Income from Cont. Operations results by quarter and year




ADMA Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -10.56 -18.04 -12.98
III Quarter September - -11.44 -15.14 -15.20
II Quarter June - -13.21 -14.75 -9.04
I Quarter March -19.25 -13.07 -17.82 -6.54
FY   -19.25 -48.28 -65.75 -43.76



ADMA Income from Cont. Operations first quarter 2020 Y/Y Growth Comment
Adma Biologics Inc in the first quarter recorded loss from continued operations of $ -19.25 millions.

According to the results reported in the first quarter, Adma Biologics Inc achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Adma Biologics Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the first quarter.




ADMA Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Adma Biologics Inc 's first quarter 2020 Income from Cont. Operations $ -19.25 millions ADMA's Income Statement
Adma Biologics Inc 's first quarter 2019 Income from Cont. Operations $ -13.07 millions Quarterly ADMA's Income Statement
New: More ADMA's historic Income from Cont. Operations Growth >>


ADMA Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Adma Biologics Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADMA's I. Quarter Q/Q Income from Cont. Operations Comment
Current results of -19.25 millions by Adma Biologics Inc look even worse compare to the -10.56 millions loss from continued operations in the previous quarter.

Within Biotechnology & Drugs industry Adma Biologics Inc achieved highest sequential Income from Cont. Operations growth. While Adma Biologics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADMA's I. Quarter Q/Q Income from Cont. Operations Comment
I. Quarter 2020 loss from continued operations of -19.25 millions by Adma Biologics Inc look even less good considering the loss from continued operations -10.56 millions in the forth quarter.

Within Biotechnology & Drugs industry Adma Biologics Inc achieved highest sequential Income from Cont. Operations growth. While Adma Biologics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Adma Biologics Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -54.46 $ -48.28 $ -55.76 $ -59.45 $ -60.99
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Adma Biologics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Adma Biologics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ADMA's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ADMA's Competitors
Income from Cont. Operations Growth for Adma Biologics Inc 's Suppliers
Income from Cont. Operations Growth for ADMA's Customers

You may also want to know
ADMA's Annual Growth Rates ADMA's Profitability Ratios ADMA's Asset Turnover Ratio ADMA's Dividend Growth
ADMA's Roe ADMA's Valuation Ratios ADMA's Financial Strength Ratios ADMA's Dividend Payout Ratio
ADMA's Roa ADMA's Inventory Turnover Ratio ADMA's Growth Rates ADMA's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2020
Nature s Sunshine Products inc   73.86 %$ 73.858 millions
Pro Dex Inc  65.71 %$ 65.710 millions
Corcept Therapeutics Inc  64.52 %$ 64.523 millions
Tenax Therapeutics Inc   64.13 %$ 64.126 millions
Quidel Corp  61.96 %$ 61.959 millions
Resmed Inc   54.76 %$ 54.755 millions
Johnson and Johnson  54.60 %$ 54.601 millions
Medpace Holdings inc   50.82 %$ 50.818 millions
Ensign Group Inc  49.24 %$ 49.241 millions
Semler Scientific Inc   44.17 %$ 44.175 millions
National Research Corporation  43.42 %$ 43.424 millions
Iqvia Holdings Inc   35.82 %$ 35.821 millions
Zoetis Inc   35.58 %$ 35.577 millions
West Pharmaceutical Services Inc   34.12 %$ 34.116 millions
Select Medical Holdings Corp  32.06 %$ 32.064 millions
Meridian Bioscience Inc  31.93 %$ 31.928 millions
Masimo Corp  30.68 %$ 30.684 millions
China Health Industries Holdings Inc   29.27 %$ 29.273 millions
Anika Therapeutics Inc   28.53 %$ 28.533 millions
Chemed Corporation  25.13 %$ 25.128 millions
Zynex Inc  24.98 %$ 24.979 millions
Edwards Lifesciences Corporation  24.39 %$ 24.389 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSW's Profile

Stock Price

OSW's Financials

Business Description

Fundamentals

Charts & Quotes

OSW's News

Suppliers

OSW's Competitors

Customers & Markets

Economic Indicators

OSW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071